Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1992, ET Capital Limited is based in southern England and focuses on high-growth technology businesses. The firm has managed multiple funds, including those targeting science-based clusters around Cambridge, Oxford, and London. ET Capital has been managing investments for Cambridge Research & Innovation Limited since 2004.
ET Capital invests in early-stage technology businesses, primarily in biotech, climate, and information technology sectors. The firm typically engages in pre-seed to Series A funding rounds, with a keen interest in companies that demonstrate potential for scaling, especially in China. Their funds, such as UK China Enterprise and Carbon Order, emphasize innovative technology applications and climate impact.
Notable companies in ET Capital's portfolio include ADC Therapeutics, which went public on the NYSE in May 2020; Carbon Engineering, acquired by Occidental Petroleum for $1.1 billion in August 2023; and Spirogen, acquired by AstraZeneca in 2013. Other investments include Bango, a mobile payments provider that floated on AIM in 2005, and Cambridge Display Technology, acquired by Sumitomo Chemical Co Ltd.
Email info@etcapital.com with your deck to pitch ET Capital.
As of August 2023: ET Capital's portfolio company Carbon Engineering was acquired by Occidental Petroleum for $1.1 billion, marking a significant exit for the firm.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.